• Home
  • Press
  • Contact
  • Menu
  • Skip to right header navigation
  • Skip to main content

TearClear logo

Preservative-free ophthalmic drug delivery

  • Home
  • Press
  • Contact

TearClear is an ophthalmic pharmaceutical company transforming trusted drugs into best-in-class therapies for patients with chronic eye disease and ocular surface disease. Our lead candidates in glaucoma will pave the way for future indications across multiple programs in development.

What People are Saying

Bill Link, PhD

Ophthalmology has been looking to address this unmet need for a long time. TearClear is developing a simple and effective technology that will truly benefit the patient.

Richard Lindstrom, MD

BAK has been shown to be a significant cause of a host of adverse events with prolonged use… TearClear’s technology offers a compelling and differentiated approach to eliminating the preservative before delivery while allowing it to preserve sterility within the bottle.

Darrell E. White, MDHealio Ocular Surgery News

My bet is that TearClear is the transformative product of OIS/AAO.

FacebookTweetLinkedInEmailPrint

Copyright © 2017–2023 TearClear Corp · All Rights Reserved · Design and development by Sky Dog Technologies

Share this ArticleLike this article? Email it to a friend!

Email sent!